Wang Man, Qu Ying, Wang Shujin, Qu Zhongsen
Department of Rehabilitation, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200233, China.
Department of Neurology, Kunming Medical University, Kunming 650500, China.
Open Med (Wars). 2024 Nov 29;19(1):20241095. doi: 10.1515/med-2024-1095. eCollection 2024.
To explore the role of oxidative stress on glycogen synthase kinase-3 in lymphocytes of diabetes mellitus (DM) patients complicated with cerebral infarction (CI).
A total of 186 DM patients were enrolled according to the inclusion criteria and exclusion criteria, including 89 DM patients alone (DM group) and 97 DM patients with CI (DM + CI) group. Eighty-one patients with CI were selected as the CI group, and 80 normal subjects over 50 years were selected as the control group. Superoxide dismutase (SOD) activity, glutathione peroxidase (GSH-Px) activity, and malondialdehyde (MDA) content in serum were determined by colorimetric assays. Phosphorylation of GSK-3β was measured by enzyme-linked immunosorbent assay.
(1) Compared with the control group, the SOD and GSH-Px activities in the DM group and DM + CI group were decreased, accompanied by higher MDA content. Furthermore, phosphorylation of GSK-3β was decreased. (2) In the DM + CI group, SOD activity was decreased on days 7 and 10 and month 3 compared to the CI group and was decreased on day 7 compared to the DM group. MDA content was increased from day 0 to month 3 compared to the CI group. On days 1, 7, and 10, GSH-Px activity was lower than the DM group, and on day 10 and month 3, it was lower than the CI group. Phosphorylation of GSK-3β was decreased on days 7 and 10 compared to the DM group and was decreased from day 1 to month 3 compared to the CI group.
In the present study, we demonstrated that the oxidative stress in peripheral lymphocytes of DM patients complicated with CI was stronger, and the GSK-3 activity was higher. It suggested that oxidative stress might enhance the GSK-3 activity, which might provide a diagnostic and therapeutic approach for DM complicated with CI, and targeting GSK-3 is a promising therapeutic target for the treatment of type 2 diabetes and its complications.
探讨氧化应激在糖尿病(DM)合并脑梗死(CI)患者淋巴细胞中对糖原合酶激酶-3的作用。
根据纳入标准和排除标准共纳入186例DM患者,包括89例单纯DM患者(DM组)和97例合并CI的DM患者(DM+CI组)。选取81例CI患者作为CI组,选取80例50岁以上正常受试者作为对照组。采用比色法测定血清中超氧化物歧化酶(SOD)活性、谷胱甘肽过氧化物酶(GSH-Px)活性和丙二醛(MDA)含量。采用酶联免疫吸附测定法检测糖原合酶激酶-3β(GSK-3β)的磷酸化水平。
(1)与对照组相比,DM组和DM+CI组的SOD和GSH-Px活性降低,同时MDA含量升高。此外,GSK-3β的磷酸化水平降低。(2)与CI组相比,DM+CI组在第7天、第10天和第3个月时SOD活性降低,与DM组相比在第7天时降低。与CI组相比,MDA含量从第0天至第3个月升高。在第1天、第7天和第10天,GSH-Px活性低于DM组,在第10天和第3个月时低于CI组。与DM组相比,GSK-3β的磷酸化水平在第7天和第10天降低,与CI组相比从第1天至第3个月降低。
在本研究中,我们证明DM合并CI患者外周淋巴细胞中的氧化应激更强,且糖原合酶激酶-3(GSK-3)活性更高。这表明氧化应激可能增强GSK-3活性,这可能为DM合并CI提供一种诊断和治疗方法,并且靶向GSK-3是治疗2型糖尿病及其并发症的一个有前景的治疗靶点。